key: cord-0822771-j127sgms
authors: Michaelsen, T. Y.; Bennedbaek, M.; Christiansen, L. E.; Jorgensen, M. S. F.; Moller, C. H.; Sorensen, E. A.; Knutsson, S.; Brandt, J.; Jensen, T. B. N.; Chiche-Lapierre, C.; Collados, E. F.; Sorensen, T.; Petersen, C.; Le-Quy, V.; Sereika, M.; Hansen, F. T.; Rasmussen, M.; Fonager, J.; Karst, S. M.; Marvig, R. L.; Stegger, M.; Sieber, R.; Skov, R. L.; Legarth, R.; Krause, T. G.; Fomsgaard, A.; Danish Covid-19 Genome Consortium,; Albertsen, M.
title: Introduction and transmission of SARS-CoV-2 B.1.1.7 in Denmark
date: 2021-06-07
journal: nan
DOI: 10.1101/2021.06.04.21258333
sha: 2dac5cc9e665074818bd6ae94eeb3b844d35a4ce
doc_id: 822771
cord_uid: j127sgms

In early 2021, the SARS-CoV-2 lineage B.1.1.7 became dominant across large parts of the world. In Denmark, comprehensive and real-time test, contact-tracing, and sequencing efforts were applied to sustain epidemic control. Here, we use these data to investigate the transmissibility, introduction, and onward transmission of B.1.1.7 in Denmark. In a period with stable restrictions, we estimated an increased B.1.1.7 transmissibility of 58% (95% CI: [56%,60%]) relative to other lineages. Epidemiological and phylogenetic analyses revealed that 37% of B.1.1.7 cases were related to the initial introduction in November 2020. Continuous introductions contributed substantially to case numbers, highlighting the benefit of balanced travel restrictions and self-isolation procedures coupled with comprehensive surveillance efforts, to sustain epidemic control in the face of emerging variants.

A year into the SARS-CoV-2 pandemic it became clear that variants with increased transmissibility and/or reduced vaccine efficacy would have a profound impact on our lives, including prolongation of the pandemic as well as increasing morbidity and mortality. On 14 December 2020, Denmark received a notification from the Early Warning and Response System of the European Union (EWRS) about a novel SARS-CoV-2 lineage (B.1.1.7) spreading fast throughout the United Kingdom (UK). The notification was a direct response to genomic sequences uploaded to the GISAID database by the Danish Covid-19 Genome Consortium (DCGC). On 18 December 2020, the New and Emerging Respiratory Virus Threats Advisory 45 Group (NERVTAG), advisers to the British Health Authorities, released a public statement, reporting a 71% (95% CI: [67%,75%]) increased transmissibility for the B.1.1.7 lineage and elevated it to variant-of-concern (VOC) (1) . The B.1.1.7 lineage appeared in the UK in September 2020 and has since spread across the world (2) , including Denmark where the first identified case was sampled on 14 November 2020 (3) . Several studies have since estimated an increased 50 transmissibility of B.1.1.7, ranging from 29% to 90% (4) (5) (6) (7) . This is in line with early estimates of 36%-55% from Denmark (8, 9) . Hypotheses for increased transmissibility include higher viral load, longer infection period, and better receptor binding (10) (11) (12) .

The B.1.1.7 lineage contains several genetic changes compared to the specimens first identified in Wuhan, China. Most notably is the spike protein amino acid substitution N501Y 55 which enhances binding to the ACE2 receptor and is thought to increase transmissibility (12) . Acquired mutations can be used to construct the phylogenetic relationship between genomes and by coupling with temporal information, transmission timing and dynamics of emerging lineages can be inferred (13) . These approaches have been used by several studies to gain insights into the SARS-CoV-2 pandemic on a national level (6, 7, (14) (15) (16) (17) . 60 Due to the early warning from the UK and an already extensive sequencing effort in Denmark, it was possible to predict growth dynamics for B.1.1.7 in Denmark, when it was still less than 2% of all circulating SARS-CoV-2 lineages. Hence, on 2 January 2021, B.1.1.7 was predicted to exceed 50% relative abundance nationwide in the middle of February (3, 18) , which formed a key argument in the political decision to further extend the lockdown at the time and 65 intensify contact tracing on all B.1.1.7 cases (19) . In this study we substantiate early results by providing an updated estimate of increased transmissibility of B.1.1.7. Furthermore, using the detailed and comprehensive nationwide data, we outline the dynamics of B.1.1.7 in Denmark to evaluate the impact of introductions and regional restrictions on the prevalence and spread of B.1.1.7. 70 We modelled the growth rate of B.1.1.7 relative to other lineages in the period from 4 January to 7 February 2021. The study period was chosen as both the PCR testing and sequencing capacity increased substantially until January, reaching a weekly rate of >13,000 tests pr. 100,000 people and >75% of all positive samples having a high-quality genome ( fig. 1A, fig. S1 ). Furthermore, a window with stable restrictions was enforced from January 4th until partial 75 reopening of primary schools from February 8th. A Poisson regression model was fitted on daily counts of B.1.1.7 to estimate increased transmissibility of B.1.1.7 relative to all other lineages. We found a growth rate of 0.021 and -0.062 per day for B.1.1.7 and other lineages respectively, corresponding to an increased transmissibility of 58% (95% CI: [56%,60%]) for B.1.1.7 assuming a generation time of 5.5 days (10, 20) . We did not observe significant differences in transmissibility Introductions into Denmark and onward transmission between regions were investigated using a time-scaled phylogenetic tree of 1976 Danish B.1.1.7 genomes and 3611 representative international sequences from outside Denmark (fig 2A) . We used pastML (21) to perform an 90 ancestral state reconstruction, to infer if sequences were introduced from outside Denmark or transmitted from another Danish region. We define an introduction lineage as a phylogenetic group of Danish sequences that share the same introduction event, similar to the definition of UK transmission lineages in (15). We do not infer the timing of introduction events from the phylogeny (7, 15, 22) , but instead use the first occurrence of an introduction lineage as a proxy justified by 95 the intense testing and high sequencing rate ( fig. S1 ). An introduction lineage can be further subdivided into transmission clusters from the ancestral state reconstruction, which is based on the regional and temporal sub-distributions of an introduction lineage. The inferred connections between transmission clusters outlines the direction of transmission between regions. The first cases of B. Interestingly, all transmission clusters appearing up until week 1 in North Denmark were not observed in the remaining study period, which were not true for other regions where a constant level of sustained transmission was present for many larger transmission clusters ( fig. 3A ). In North Denmark, 7 of 11 municipalities had elevated restrictive measures until 16 November 2020 115 due to circulation of mink-related lineages (23). The intensified contact-tracing and genomic surveillance in that period likely kept the reproductive numbers for North Denmark below that of other Danish regions, making it difficult for any cluster to develop from local to sustained transmission. B.1.1.7 was only designated as VOC from late December 2020 onwards (1) and authorities were not able to do sufficient genome-based contact tracing due to low number of 120 samples sequenced (around 25% of positive cases) and slow turnaround (median 11 days) at that time. Therefore, the dynamics in North Denmark is likely not attributed to focused contact tracing of B.1.1.7. This contrasts the current situation in June 2021, with substantially improved sequencing capacity (>90% of positive cases and median 5 days turnaround) and rapid mutation of concern screening to initiate contact tracing (24, 25). cases of the same introduction lineage to be introduction-related, while later cases occur due to sustained transmission in society. To evaluate this, we incremented the number of follow-up days All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 7, 2021. ; https://doi.org/10.1101/2021.06.04.21258333 doi: medRxiv preprint for cases to be assigned as introduction-related ( fig. 3C) . Overall, the relative contribution of introduction-related cases peaked during onset of B.1.1.7 and again in mid-January ( fig. 3C ). Introductions alone (follow-up =0 days in fig. 3C ) accounted for around 5%-10% of all cases with substantial temporal variation. This is comparable to a US study on data from the first half of 2020, where travel restrictions also applied (22) . Using 14 days follow-up since the first occurrence of an introduction to define introduction-related cases within the same introduction lineage, there were periods where >50% of cases were due to importation from outside Denmark ( fig. 3C ) despite travel-restrictions and self-isolation recommendations being in place. 140 In collaboration with the Danish Patient Safety Authority which administers the contact tracing efforts in Denmark, we performed detailed epidemiological investigations of registry data to identify direct or indirect travel links for all 1976 cases in this study. A total of 62 persons infected with B.1.1.7 (3%) had recorded travel history to 23 different destinations. The most frequent destinations were the United Arab Emirates (n = 21), United Kingdom (n = 5), and 145 Pakistan (n = 4). We were able to associate 32 (31%) introductions directly to travelling ( fig. 3A,  fig. S5 ). We performed a separate ancestral state reconstruction with country-level resolution on international sequences, allowing us to compare the phylogenetically inferred origin to the travel history. Of 33 introductions with travel history, 9 (27%) matched by country and 12 (36%) by high-level geographical region. This highlights the limitations of available genomic data, which is 150 still heavily biased both geographically and temporally (26) from spreading to Denmark (28) . Despite these restrictions, our study shows a substantial impact of introductions, suggesting that country-specific restrictions and non-enforced recommendations of self-isolation might be insufficient. Finally, VOC designation of B.1.1.7 and upscaling of capacity in Denmark was too late to hinder the takeover of this lineage, which had to be managed by broad societal restrictions. However, real-time testing, genomic tracking and contact-tracing is 180 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 7, 2021. Acknowledgments 355 We gratefully acknowledge the Danish hospitals for local sequencing and data sharing. Thanks to all data contributors from outside Denmark, including the authors and their originating laboratories responsible for obtaining the specimens, as well as their submitting laboratories for generating the genetic sequence and metadata and sharing it via the GISAID Initiative. We would like to acknowledge the people at Data Integration and Analysis (DIAS), Statens Serum Institute, for 360 managing and maintaining the national MiBa database which much of this work is based on. Thanks to the people at the Danish Patient Safety Authority for providing us with detailed travel records of SARS-CoV-2 positive cases. Thanks to Anna Zhukova, Institut Pasteur for modifying the pastML software to better fit our needs upon request. Finally, a sincere thanks to Edyth Parker, Scripps Research, for insightful phylogenetic discussions. 

All authors declare no competing interests.

This study was conducted on administrative register data. According to Danish law, informed consent is not needed for such research as the publication only contains aggregated results and no 380 personal data is shown. The epidemiological data used in this work is person-sensitive and we are prohibited to make it publicly available according to Danish legislation. SARS-CoV-2 consensus genome sequences associated with this work have been uploaded to the GISAID database in accordance with Danish law (no. 285 vers. 2021-02-27). As consequence, dates are binned by week and maximum spatial resolution is at regional level. Accession numbers are available in the 385 Supplementary Materials (data file S1). All code used to run the phylogenetic analysis, Poisson regression models, and generate the visualizations used in this work is available at https://github.com/TYMichaelsen/B117-DK-introduction.

List of Danish Covid-19 Genome Consortium members Figs. S1 to S4 Data file S1 References (12, 21, (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) (41) (42) (43) (44) (45) (46) height corresponds to the total number of cases for each week. Green bars indicate the number of cases for which a high-quality genome was available (less than 3000 ambiguous bases). (B) relative abundance of ten most abundant PANGO lineages across Denmark in the study period. Computed from rolling averages of daily cases with genome available over a 14-days window. Less abundant lineages are not shown but included in the unfilled area of the plots. The black dot 405 and date corresponds to the point where B.1.1.7 crosses 50% relative abundance. All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. If there was equal support for multiple regions as origin for an introduction Denmark was used as the origin. Label notDK indicates an introduction from outside Denmark. Only ancestral state changes with a marginal probability >95% were included in the analysis. 435 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 7, 2021. ; https://doi.org/10.1101/2021.06.04.21258333 doi: medRxiv preprint

NERVTAG meeting on SARS-CoV-2 variant under investigation VUI-202012/01

Risk related to the spread of new SARS-CoV-2 variants of concern in the EU/EEA -first update

SARS-CoV-2-virusvarianter. SSI's portal med information om

Washburne, Others, Estimated transmissibility and severity of novel SARS-CoV-2 Variant of Concern

The Wellcome Sanger Institute Covid-19 Surveillance Team, The COVID-19 Genomics UK (COG-UK) Consortium, Genomic 200 reconstruction of the SARS-CoV-2 epidemic across England from

B.1.1.7 in the United States

Prognoser for smittetal med fokus på udviklingen i cluster B.1.1.7

Notat om prognoser for smittetal og indlaeggelser ved scenarier for genåbning af 0.-4. klasse i grundskolen

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

Infection sustained by lineage B.1.1.7 of SARS-CoV-2 is characterised by longer persistence and higher viral RNA loads 235 in nasopharyngeal swabs

Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations

Phylogenetic analysis of SARS-CoV-2 data is difficult

A Phylodynamic Workflow to Rapidly Gain Insights into the Dispersal History and Dynamics of SARS-CoV-2 Lineages

COVID-19 Genomics UK (COG-UK) Consortium, D. M. Aanensen

CoV-2 epidemic in the UK

Sixteen novel lineages of SARS-CoV-2 in South Africa

Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2

Scenarier for udviklingen i den engelske virusvariant af SARS-COV-2 (cluster B.1.1.7)

Skaerpelse af rejsevejledninger og indrejserestriktioner

Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe

A Fast Likelihood Method to Reconstruct and Visualize Ancestral Scenarios

Viral genomes reveal patterns of the SARS-CoV-2 outbreak in Washington State

Sanger sequencing part of the spike protein gene. medRxiv (2021)

Delta-PCR-testen. SSI's portal med information om covid-19

Submission Tracker Global. gisaid.org (2021)

Nationalt Kommunikationscenter -COVID-19 (NKC)

Download fil med overvågningsdata. SSI's portal med information om covid-19

The Danish Covid-19 Genome Consortium

nCov-2019 sequencing protocol V.1. protocols.io (2020)

AAU-nCoV-2019 Tailed Long Amplicon Sequencing. protocols.io

Cutadapt removes adapter sequences from high-throughput sequencing reads

nCoV-2019 novel coronavirus bioinformatics protocol. ARTIC network (2020)

Bolker, glmmTMB balances speed and flexibility among 325 packages for zero-inflated generalized linear mixed modeling

A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology

MAFFT multiple sequence alignment software version 7: improvements in performance and usability

Others, Some probabilistic and statistical problems in the analysis of DNA sequences. Lectures on mathematics in the life sciences

A space-time process model for the evolution of DNA sequences

ModelFinder: fast model selection for accurate phylogenetic estimates

Exploring the temporal structure of heterochronous sequences using TempEst (formerly Path-O-Gen)

Ultrafast approximation for phylogenetic bootstrap

Fast Dating Using Least-Squares Criteria and Algorithms

Origin, evolution 350 and global spread of SARS-CoV-2

Evolutionary trees from DNA sequences: a maximum likelihood approach